KR102482699B1 - N,n''-비스-2-머캅토에틸 이소프탈아미드의 용도 - Google Patents
N,n''-비스-2-머캅토에틸 이소프탈아미드의 용도 Download PDFInfo
- Publication number
- KR102482699B1 KR102482699B1 KR1020167030801A KR20167030801A KR102482699B1 KR 102482699 B1 KR102482699 B1 KR 102482699B1 KR 1020167030801 A KR1020167030801 A KR 1020167030801A KR 20167030801 A KR20167030801 A KR 20167030801A KR 102482699 B1 KR102482699 B1 KR 102482699B1
- Authority
- KR
- South Korea
- Prior art keywords
- nbmi
- patient
- pharmaceutical composition
- smoker
- delete delete
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- Y10S514/849—
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1406115.4 | 2014-04-04 | ||
| GB1406115.4A GB2524831A (en) | 2014-04-04 | 2014-04-04 | New pharmaceutical use |
| PCT/GB2015/050999 WO2015150793A1 (en) | 2014-04-04 | 2015-03-31 | New use of n,n-bis-2-mercaptoethyl isophthalamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20160140929A KR20160140929A (ko) | 2016-12-07 |
| KR102482699B1 true KR102482699B1 (ko) | 2022-12-28 |
Family
ID=50776843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020167030801A Active KR102482699B1 (ko) | 2014-04-04 | 2015-03-31 | N,n''-비스-2-머캅토에틸 이소프탈아미드의 용도 |
Country Status (36)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202005057D0 (en) | 2020-04-06 | 2020-05-20 | Emeramed Ltd | New Use |
| CN114778234B (zh) * | 2022-03-18 | 2025-08-15 | 武汉新烽光电股份有限公司 | 一种用于微流控总磷测试的抗坏血酸溶液的保存方法及保存结构 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100227812A1 (en) | 2008-12-06 | 2010-09-09 | Haley Boyd E | Method of supplementing the diet and ameliorating oxidative stress |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6586600B2 (en) | 2000-12-06 | 2003-07-01 | University Of Kentucky Research Foundation | Multidentate sulfur-containing ligands |
| JP2011026204A (ja) * | 2007-11-26 | 2011-02-10 | Rei Furukawa | タバコの煙を吸入することにより引き起こされる疾患の予防及び／又は治療用組成物 |
| US8575218B2 (en) * | 2009-09-28 | 2013-11-05 | The University Of Kentucky Research Foundation | Thiol-containing compounds for the removal of elements from tissues and formulations therefor |
| AU2010297933A1 (en) | 2009-09-28 | 2012-04-19 | University Of Kentucky Research Foundation | Thiol-containing compounds for the removal of elements from contaminated milieu and methods of use |
| US8426368B2 (en) | 2010-03-25 | 2013-04-23 | The University Of Kentucky Research Foundation | Method of ameliorating oxidative stress and supplementing the diet |
| US20110237776A1 (en) | 2010-03-25 | 2011-09-29 | Haley Boyd E | Aromatic compounds with sulfur containing ligands |
-
2014
- 2014-04-04 GB GB1406115.4A patent/GB2524831A/en not_active Withdrawn
-
2015
- 2015-03-31 SG SG11201607478RA patent/SG11201607478RA/en unknown
- 2015-03-31 MX MX2016012591A patent/MX2016012591A/es active IP Right Grant
- 2015-03-31 UA UAA201611073A patent/UA119558C2/uk unknown
- 2015-03-31 ES ES15723546.6T patent/ES2659174T3/es active Active
- 2015-03-31 HR HRP20180325TT patent/HRP20180325T1/hr unknown
- 2015-03-31 PT PT157235466T patent/PT3125876T/pt unknown
- 2015-03-31 WO PCT/GB2015/050999 patent/WO2015150793A1/en not_active Ceased
- 2015-03-31 AU AU2015242374A patent/AU2015242374B2/en active Active
- 2015-03-31 PE PE2016001785A patent/PE20170586A1/es unknown
- 2015-03-31 US US15/129,654 patent/US9782368B2/en active Active
- 2015-03-31 ME MEP-2018-50A patent/ME03012B/me unknown
- 2015-03-31 HU HUE15723546A patent/HUE036206T2/hu unknown
- 2015-03-31 SI SI201530158T patent/SI3125876T1/en unknown
- 2015-03-31 NO NO15723546A patent/NO3125876T3/no unknown
- 2015-03-31 NZ NZ724678A patent/NZ724678A/en unknown
- 2015-03-31 EP EP15723546.6A patent/EP3125876B8/en active Active
- 2015-03-31 KR KR1020167030801A patent/KR102482699B1/ko active Active
- 2015-03-31 EA EA201692013A patent/EA032116B1/ru unknown
- 2015-03-31 SM SM20180116T patent/SMT201800116T1/it unknown
- 2015-03-31 BR BR112016022880-4A patent/BR112016022880B1/pt active IP Right Grant
- 2015-03-31 MA MA39833A patent/MA39833B1/fr unknown
- 2015-03-31 PL PL15723546T patent/PL3125876T3/pl unknown
- 2015-03-31 CA CA2944113A patent/CA2944113C/en active Active
- 2015-03-31 LT LTEP15723546.6T patent/LT3125876T/lt unknown
- 2015-03-31 CN CN201580017210.4A patent/CN106132405B/zh active Active
- 2015-03-31 RS RS20180210A patent/RS56905B1/sr unknown
- 2015-03-31 JP JP2016557313A patent/JP6474423B2/ja active Active
- 2015-03-31 DK DK15723546.6T patent/DK3125876T3/en active
-
2016
- 2016-09-16 ZA ZA2016/06406A patent/ZA201606406B/en unknown
- 2016-09-25 IL IL248027A patent/IL248027B/en active IP Right Grant
- 2016-09-30 CL CL2016002499A patent/CL2016002499A1/es unknown
- 2016-09-30 EC ECIEPI201678100A patent/ECSP16078100A/es unknown
- 2016-10-01 SA SA516371966A patent/SA516371966B1/ar unknown
- 2016-10-04 PH PH12016501975A patent/PH12016501975A1/en unknown
-
2018
- 2018-02-09 CY CY20181100160T patent/CY1121235T1/el unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100227812A1 (en) | 2008-12-06 | 2010-09-09 | Haley Boyd E | Method of supplementing the diet and ameliorating oxidative stress |
Non-Patent Citations (2)
| Title |
|---|
| Therapeutic Advances in Respiratory Disease vol.2, no.6, pp.351-374 (2008.12.01.) |
| Toxicology Mechanisms and Methods vol.22, no.5, pp.383-396 (2012.06.01.) |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2685706C2 (ru) | Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением | |
| Rogers et al. | Inhibition of cigarette smoke-induced airway secretory cell hyperplasia by indomethacin, dexamethasone, prednisolone, or hydrocortisone in the rat | |
| Mekonnen et al. | A review of upper airway physiology relevant to the delivery and deposition of inhalation aerosols | |
| KR102482699B1 (ko) | N,n''-비스-2-머캅토에틸 이소프탈아미드의 용도 | |
| US20180338936A1 (en) | Methods and Compositions for the Treatment and Prevention of Allergic Rhinitis | |
| TWI375671B (en) | Pharmaceutical compositions containing brazilin for inhibiting expression of cytokines of t helper cell type ii and/or inhibiting expression of chemokines and uses of the same | |
| HK1228798B (en) | New use of n,n-bis-2-mercaptoethyl isophthalamide | |
| HK1228798A1 (en) | New use of n,n-bis-2-mercaptoethyl isophthalamide | |
| Al-Khalaf et al. | Oxidants and antioxidants status in bronchial asthma | |
| Haroon et al. | THE EFFECT OF HOOKAH (SHISA) AND VAPING ON CARDIOVASCULAR DISEASE: A LITERATURE REVIEW. | |
| CN107281201A (zh) | 虎杖苷在预防和治疗大气污染物pm2.5所致肺部损伤的应用 | |
| JP2015509509A (ja) | 慢性閉塞性疾患を治療するための医薬品組成物の製造のための、ルパタジンの使用 | |
| CN116617215A (zh) | 一种改善肺部疾病的组合物及其应用 | |
| CN115400201A (zh) | Ss-31在制备预防和/或治疗香烟诱导的气道炎症及慢性阻塞性肺疾病的药物中的用途 | |
| JP2019511556A (ja) | イソグリチルリチン酸またはその塩の吸入製剤および呼吸器疾患を治療する薬物の製造におけるそれらの応用 | |
| CN120827552A (zh) | 一种银杏双黄酮在治疗慢性肺阻塞中的应用 | |
| Bartošová et al. | 229. rhDNase in Czech CF patients | |
| TWI468170B (zh) | 薑化合物之用途 | |
| Wilkinson et al. | 232. Compliance with nebulised RhDNase in children with cystic fibrosis (CF) | |
| JP2022014868A (ja) | 慢性閉塞性肺疾患の急性増悪の治療薬の調製におけるＴａｎｒｅｑｉｎｇの応用 | |
| US20220160804A1 (en) | Use of laurus nobilis extract fractions to protect against air pollution related diseases | |
| Asfazadour et al. | 230. Effects of rh-DNAse in cystic fibrosis | |
| Pavlov et al. | 231. Immune response of macroorganism of CF patients on treatment of rhDNase | |
| Leigh | Inhaled corticosteroids in asthma | |
| Doughty | The Potentiating Effects of Acetaminophen on Oxidant Air Pollutant Sensory Irritation and the Onset of Asthma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U12-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE) Year of fee payment: 4 |